BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30715585)

  • 21. Diffusion-weighted MRI and 18F-FDG-PET/CT imaging: competition or synergy as diagnostic methods to manage sarcoma of the uterus? A systematic review of the literature.
    Dubreuil J; Tordo J; Rubello D; Giammarile F; Skanjeti A
    Nucl Med Commun; 2017 Jan; 38(1):84-90. PubMed ID: 27898647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis.
    Gődény M; Lengyel Z; Polony G; Nagy ZT; Léránt G; Zámbó O; Remenár É; Tamás L; Kásler M
    Cancer Imaging; 2016 Nov; 16(1):38. PubMed ID: 27814768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    Kirchner J; Sawicki LM; Deuschl C; Grüneisen J; Beiderwellen K; Lauenstein TC; Herrmann K; Forsting M; Heusch P; Umutlu L
    PLoS One; 2017; 12(7):e0180349. PubMed ID: 28683109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis.
    Daamen LA; Groot VP; Goense L; Wessels FJ; Borel Rinkes IH; Intven MPW; van Santvoort HC; Molenaar IQ
    Eur J Radiol; 2018 Sep; 106():128-136. PubMed ID: 30150034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    Am J Otolaryngol; 2019; 40(2):297-305. PubMed ID: 30473166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-weighted MRI versus FDG-PET/CT for diagnosing pancreatic cancer: an indirect comparison meta-analysis.
    Que R; Chen Y; Tao Z; Ge B; Li M; Fu Z; Li Y
    Acta Radiol; 2020 Nov; 61(11):1473-1483. PubMed ID: 32148066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-Body
    Sheikhbahaei S; Marcus CV; Fragomeni RS; Rowe SP; Javadi MS; Solnes LB
    J Nucl Med; 2017 Jul; 58(7):1031-1036. PubMed ID: 27980049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
    Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Performance of Whole-Body MRI and FDG PET/CT in Evaluation of Multiple Myeloma Treatment Response: Systematic Review and Meta-Analysis.
    Rama S; Suh CH; Kim KW; Durieux JC; Ramaiya NH; Tirumani SH
    AJR Am J Roentgenol; 2022 Apr; 218(4):602-613. PubMed ID: 34704461
    [No Abstract]   [Full Text] [Related]  

  • 32. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
    Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
    Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis.
    Kroese TE; Goense L; van Hillegersberg R; de Keizer B; Mook S; Ruurda JP; van Rossum PSN
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29917073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of diffusion-weighted imaging versus 18F-FDG PET/CT in differentiating pulmonary lesions: an updated meta-analysis of comparative studies.
    Liu J; Xia X; Zou Q; Xie X; Lei Y; Wan Q; Li X
    BMC Med Imaging; 2023 Mar; 23(1):37. PubMed ID: 36899303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of liver metastases in patients with adenocarcinomas of the gastrointestinal tract: comparison of (18)F-FDG PET/CT and MR imaging.
    Maegerlein C; Fingerle AA; Souvatzoglou M; Rummeny EJ; Holzapfel K
    Abdom Imaging; 2015 Jun; 40(5):1213-22. PubMed ID: 25348732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of pre-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis.
    Han S; Woo S; Suh CH; Lee JJ
    J Gynecol Oncol; 2018 Nov; 29(6):e98. PubMed ID: 30207106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X; Huang X; Yan W; Wu L; Dai K
    Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing the diagnostic efficacy of [
    Xia L; Lai J; Huang D; Qiu S; Hu H; Luo Y; Cao J
    Radiol Oncol; 2023 Sep; 57(3):299-309. PubMed ID: 37494596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer.
    Hempel JM; Kloeckner R; Krick S; Pinto Dos Santos D; Schadmand-Fischer S; Boeßert P; Bisdas S; Weber MM; Fottner C; Musholt TJ; Schreckenberger M; Miederer M
    Cancer Imaging; 2016 Nov; 16(1):37. PubMed ID: 27809936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.
    Min LA; Vogel WV; Lahaye MJ; Maas M; Donswijk ML; Vegt E; Kusters M; Zijlmans HJ; Jóźwiak K; Roberti S; Beets-Tan RGH; Lambregts DMJ
    Eur Radiol; 2019 Dec; 29(12):6900-6910. PubMed ID: 31119418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.